1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Nutrition
  4. Volume 37, 2017
  5. Article

Annual Review of Nutrition

Volume 37, 2017

Brain on Fire: Incentive Salience, Hedonic Hot Spots, Dopamine, Obesity, and Other Hunger Games

Abstract

This review examines human feeding behavior in light of psychological motivational theory and highlights the importance of midbrain dopamine (DA). Prospective evidence of both reward surfeit and reward deficit pathways to increased body weight are evaluated, and we argue that it is more complex than an either/or scenario when examining DA's role in reward sensitivity, eating, and obesity. The genotype is a common thread that ties the contrasting models of DA reward and obesity; this genotype related to striatal DA is not associated with obesity class per se but may nevertheless confer an increased risk of weight gain. We also critically examine the concept of so-called food addiction, and despite growing evidence, we argue that there is currently insufficient human data to warrant this diagnostic label. The surgical and pharmacological treatments of obesity are discussed, and evidence is presented for the selective use of DA-class drugs in obesity treatment.

Keyword(s): BMI, energy intake, fMRI, food addiction, food reward, liking, obesity surgery
Loading

Article metrics loading...

/content/journals/10.1146/annurev-nutr-071816-064855
2017-08-21
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/nutr/37/1/annurev-nutr-071816-064855.html?itemId=/content/journals/10.1146/annurev-nutr-071816-064855&mimeType=html&fmt=ahah

Literature Cited

  1. 1. Am. Psychiatr. Assoc. 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) Washington, DC: APA
  2. 2. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: APA [Google Scholar]
  3. Appel L, Bergstrom M, Buus Lassen J, Langstrom B. 3.  2014. Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET. Eur. Neuropsychopharmacol. 24:251–61 [Google Scholar]
  4. Avena NM, Hoebel BG. 4.  2003. A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine. Neuroscience 122:17–20 [Google Scholar]
  5. Axel AM, Mikkelsen JD, Hansen HH. 5.  2010. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of α1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology 35:1464–76 [Google Scholar]
  6. Benton D, Young HA. 6.  2016. A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?. Int. J. Obes. 40:Suppl. 1S12–21 [Google Scholar]
  7. Berridge KC. 7.  1996. Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 20:1–25 [Google Scholar]
  8. Berridge KC, Kringelbach ML. 8.  2015. Pleasure systems in the brain. Neuron 86:646–64 [Google Scholar]
  9. Berridge KC, Robinson TE. 9.  1998. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Rev. 28:309–69 [Google Scholar]
  10. Berthoud HR. 10.  2002. Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 26:393–428 [Google Scholar]
  11. Berthoud HR. 11.  2004. Mind versus metabolism in the control of food intake and energy balance. Physiol. Behav. 81:781–93 [Google Scholar]
  12. Berthoud HR. 12.  2007. Interactions between the “cognitive” and “metabolic” brain in the control of food intake. Physiol. Behav. 91:486–98 [Google Scholar]
  13. Berthoud HR, Morrison C. 13.  2008. The brain, appetite, and obesity. Annu. Rev. Psychol. 59:55–92 [Google Scholar]
  14. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ. 14.  et al. 2000. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoact. Drugs 32:Suppl.i–iv, 1–112 [Google Scholar]
  15. Blum K, Braverman ER, Wood RC, Gill J, Li C. 15.  et al. 1996. Increased prevalence of the TaqI A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 6:297–305 [Google Scholar]
  16. Blundell JE. 16.  1992. Psychobiology of the appetite. J. Annu. Diabetol. Hotel-Dieu 1992:239–53 [Google Scholar]
  17. Blundell JE, Finlayson G. 17.  2011. Food addiction not helpful: the hedonic component—implicit wanting—is important. Addiction 106:1216–18 Discussion. 2011. Addiction 106:1219–20 [Google Scholar]
  18. Blundell JE, Stubbs RJ, Golding C, Croden F, Alam R. 18.  et al. 2005. Resistance and susceptibility to weight gain: individual variability in response to a high-fat diet. Physiol. Behav. 86:614–22 [Google Scholar]
  19. Cameron J, Doucet E. 19.  2007. Getting to the bottom of feeding behaviour: Who's on top?. Appl. Physiol. Nutr. Metab. 32:177–89 [Google Scholar]
  20. Cameron JD, Doucet E. 20.  2011. Reinforcement and food hedonics: a look at how energy deprivation impacts food reward. Handbook of Behavior, Food and Nutrition CR Martin, VR Preedy, RR Watson 2285–305 New York: Springer [Google Scholar]
  21. Cameron JD, Riou MÈ, Tesson F, Goldfield GS, Rabasa-Lhoret R. 21.  et al. 2013. The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite 60:111–16 [Google Scholar]
  22. Carr KD. 22.  2007. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol. Behav. 91:459–72 [Google Scholar]
  23. Carter A, Hendrikse J, Lee N, Yucel M, Verdejo-Garcia A. 23.  et al. 2016. The neurobiology of “food addiction” and its implications for obesity treatment and policy. Annu. Rev. Nutr. 36:105–28 [Google Scholar]
  24. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. 24.  1993. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem. Med. Metab. Biol 50176–85 [Google Scholar]
  25. Cornelis MC, Flint A, Field AE, Kraft P, Han J. 25.  et al. 2016. A genome-wide investigation of food addiction. Obesity 24:1336–41 [Google Scholar]
  26. Davis C. 26.  2013. A narrative review of binge eating and addictive behaviors: shared associations with seasonality and personality factors. Front. Psychiatry 4:183 [Google Scholar]
  27. Davis C. 27.  2015. The epidemiology and genetics of binge eating disorder (BED). CNS Spectr 20:522–29 [Google Scholar]
  28. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. 28.  2011. Evidence that ‘food addiction’ is a valid phenotype of obesity. Appetite 57:711–17 [Google Scholar]
  29. Davis C, Fox J. 29.  2008. Sensitivity to reward and body mass index (BMI): evidence for a non-linear relationship. Appetite 50:43–49 [Google Scholar]
  30. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C. 30.  et al. 2007. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology 32:2199–206 [Google Scholar]
  31. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C. 31.  et al. 2008. Reward sensitivity and the D2 dopamine receptor gene: a case-control study of binge eating disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 32:620–28 [Google Scholar]
  32. Davis C, Levitan RD, Kaplan AS, Carter-Major JC, Kennedy JL. 32.  2016. Sex differences in subjective and objective responses to a stimulant medication (methylphenidate): comparisons between overweight/obese adults with and without binge-eating disorder. Int. J. Eat. Disord. 49:473–81 [Google Scholar]
  33. Davis C, Levitan RD, Kaplan AS, Kennedy JL, Carter JC. 33.  2014. Food cravings, appetite, and snack-food consumption in response to a psychomotor stimulant drug: the moderating effect of “food-addiction.”. Front. Psychol. 5:403 [Google Scholar]
  34. Davis C, Strachan S, Berkson M. 34.  2004. Sensitivity to reward: implications for overeating and overweight. Appetite 42:131–38 [Google Scholar]
  35. de Araujo IE, Geha P, Small DM. 35.  2012. Orosensory and homeostatic functions of the insular taste cortex. Chemosens. Percept. 5:64–79 [Google Scholar]
  36. De Silva A, Salem V, Long CJ, Makwana A, Newbould RD. 36.  et al. 2011. The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab 14:700–6 [Google Scholar]
  37. de Weijer BA, van de Giessen E, van Amelsvoort TA, Boot E, Braak B. 37.  et al. 2011. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res 1:37 [Google Scholar]
  38. Demos KE, Heatherton TF, Kelley WM. 38.  2012. Individual differences in nucleus accumbens activity to food and sexual images predict weight gain and sexual behavior. J. Neurosci. 32:5549–52 [Google Scholar]
  39. Drummond DC, Cooper T, Glautier SP. 39.  1990. Conditioned learning in alcohol dependence: implications for cue exposure treatment. Br. J. Addict. 85:725–43 [Google Scholar]
  40. Dunn JP, Kessler RM, Feurer ID, Volkow ND, Patterson BW. 40.  et al. 2012. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care 35:1105–11 [Google Scholar]
  41. Epstein LH, Dearing KK, Erbe RW. 41.  2010. Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programs. Appetite 55:363–66 [Google Scholar]
  42. Epstein LH, Leddy JJ, Temple JL, Faith MS. 42.  2007. Food reinforcement and eating: a multilevel analysis. Psychol. Bull. 133:884–906 [Google Scholar]
  43. Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ. 43.  2007. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav. Neurosci. 121:877–86 [Google Scholar]
  44. Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW Jr.. 44.  et al. 2004. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am. J. Clin. Nutr. 80:82–88 [Google Scholar]
  45. Farr OM, Li CS, Mantzoros CS. 45.  2016. Central nervous system regulation of eating: insights from human brain imaging. Metabolism 65:699–713 [Google Scholar]
  46. Farr OM, Sofopoulos M, Tsoukas MA, Dincer F, Thakkar B. 46.  et al. 2016. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia 59:954–65 [Google Scholar]
  47. Field M, Mogg K, Bradley BP. 47.  2004. Eye movements to smoking-related cues: effects of nicotine deprivation. Psychopharmacology 173:116–23 [Google Scholar]
  48. Franken IH, Kroon LY, Wiers RW, Jansen A. 48.  2000. Selective cognitive processing of drug cues in heroin dependence. J. Psychopharmacol. 14:395–400 [Google Scholar]
  49. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T. 49.  et al. 2007. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 107:1755–67 [Google Scholar]
  50. Garrido E, Palomo T, Ponce G, Garcia-Consuegra I, Jimenez-Arriero MA, Hoenicka J. 50.  2010. The ANKK1 protein associated with addictions has nuclear and cytoplasmic localization and shows a differential response of Ala239Thr to apomorphine. Neurotox. Res. 20:32–39 [Google Scholar]
  51. Gearhardt AN, Brownell KD. 51.  2013. Can food and addiction change the game?. Biol. Psychiatry 73:802–3 [Google Scholar]
  52. Gearhardt AN, Corbin WR, Brownell KD. 52.  2009. Preliminary validation of the Yale Food Addiction Scale. Appetite 52:430–36 [Google Scholar]
  53. Geha PY, Aschenbrenner K, Felsted J, O'Malley SS, Small DM. 53.  2013. Altered hypothalamic response to food in smokers. Am. J. Clin. Nutr. 97:15–22 [Google Scholar]
  54. Goldfield GS, Dowler LM, Walker M, Cameron JD, Ferraro ZM. 54.  et al. 2013. Are dopamine-related genotypes risk factors for excessive gestational weight gain?. Int. J. Women's Health 5:253–59 [Google Scholar]
  55. Goldfield GS, Lorello C, Cameron J, Chaput JP. 55.  2011. Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study. Appl. Physiol. Nutr. Metab. 36:1009–13 [Google Scholar]
  56. Goldfield GS, Lorello C, Doucet E. 56.  2007. Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food?. Am. J. Clin. Nutr. 86:308–15 [Google Scholar]
  57. Green E, Jacobson A, Haase L, Murphy C. 57.  2011. Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res 1386:109–17 [Google Scholar]
  58. Hankir MK, Ashrafian H, Hesse S, Horstmann A, Fenske WK. 58.  2015. Distinctive striatal dopamine signaling after dieting and gastric bypass. Trends Endocrinol. Metab. 26:223–30 [Google Scholar]
  59. Hansen HH, Jensen MM, Overgaard A, Weikop P, Mikkelsen JD. 59.  2013. Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacol. Biochem. Behav. 110:265–71 [Google Scholar]
  60. Havel PJ. 60.  2001. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp. Biol. Med. 226:963–77 [Google Scholar]
  61. Hebebrand J, Albayrak O, Adan R, Antel J, Dieguez C. 61.  et al. 2014. “Eating addiction,” rather than “food addiction,” better captures addictive-like eating behavior. Neurosci. Biobehav. Rev. 47:295–306 [Google Scholar]
  62. Horstmann A, Fenske WK, Hankir MK. 62.  2015. Argument for a non-linear relationship between severity of human obesity and dopaminergic tone. Obes. Rev. 16:821–30 [Google Scholar]
  63. Hoy SM. 63.  2013. Lorcaserin: a review of its use in chronic weight management. Drugs 73:463–73 [Google Scholar]
  64. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzle AG. 64.  et al. 2014. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation 129:S102–38 [Google Scholar]
  65. Johnson PM, Kenny PJ. 65.  2010. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 13:635–41 [Google Scholar]
  66. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y. 66.  et al. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4:290–96 [Google Scholar]
  67. Kelley AE, Baldo BA, Pratt WE, Will MJ. 67.  2005. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav. 86:773–95 [Google Scholar]
  68. Kessler RM, Zald DH, Ansari MS, Li R, Cowan RL. 68.  2014. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse 68:317–20 [Google Scholar]
  69. Kiyatkin EA, Gratton A. 69.  1994. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res 652:225–34 [Google Scholar]
  70. Koob GF, Le Moal M. 70.  2008. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. B 363:3113–23 [Google Scholar]
  71. Koob GF, Volkow ND. 71.  2009. Neurocircuitry of addiction. Neuropsychopharmacology 35:217–38 [Google Scholar]
  72. Kringelbach ML, Rolls ET. 72.  2004. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 72:341–72 [Google Scholar]
  73. Leddy JJ, Epstein LH, Jaroni JL, Roemmich JN, Paluch RA. 73.  et al. 2004. Influence of methylphenidate on eating in obese men. Obes. Res. 12:224–32 [Google Scholar]
  74. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA. 74.  et al. 2010. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am. J. Clin. Nutr. 91:184–90 [Google Scholar]
  75. Liang J, Matheson BE, Kaye WH, Boutelle KN. 75.  2014. Neurocognitive correlates of obesity and obesity-related behaviors in children and adolescents. Int. J. Obes. 38:494–506 [Google Scholar]
  76. Long CG, Blundell JE, Finlayson G. 76.  2015. A systematic review of the application and correlates of YFAS-diagnosed ‘food addiction’ in humans: Are eating-related ‘addictions’ a cause for concern or empty concepts?. Obes. Facts 8:386–401 [Google Scholar]
  77. Lutter M, Nestler EJ. 77.  2009. Homeostatic and hedonic signals interact in the regulation of food intake. J. Nutr. 139:629–32 [Google Scholar]
  78. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D. 78.  et al. 2012. Deficits in dopamine D2 receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol. Psychiatry 71:192–98 [Google Scholar]
  79. Miras AD, Jackson RN, Jackson SN, Goldstone AP, Olbers T. 79.  et al. 2012. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am. J. Clin. Nutr. 96:467–73 [Google Scholar]
  80. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 80.  1998. Dopamine receptors: from structure to function. Physiol. Rev. 78:189–225 [Google Scholar]
  81. Munzberg H, Laque A, Yu S, Rezai-Zadeh K, Berthoud HR. 81.  2015. Appetite and body weight regulation after bariatric surgery. Obes. Rev. 16:Suppl. 177–90 [Google Scholar]
  82. Narayanaswami V, Dwoskin LP. 82.  2016. Obesity: current and potential pharmacotherapeutics and targets. Pharmacol. Ther. 170:116–47 [Google Scholar]
  83. Need AC, Ahmadi KR, Spector TD, Goldstein DB. 83.  2006. Obesity is associated with genetic variants that alter dopamine availability. Ann. Hum. Genet. 70:293–303 [Google Scholar]
  84. Neville MJ, Johnstone EC, Walton RT. 84.  2004. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat. 23:540–45 [Google Scholar]
  85. Ng M, Fleming T, Robinson M, Thomson B, Graetz N. 85.  et al. 2013. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study. Lancet 384:766–81 [Google Scholar]
  86. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR. 86.  2011. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 36:1940–47 [Google Scholar]
  87. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. 87.  1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch. Gen. Psychiatry 48:648–54 [Google Scholar]
  88. Nolan LJ, Geliebter A. 88.  2016. “Food addiction” is associated with night eating severity. Appetite 98:89–94 [Google Scholar]
  89. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. 89.  2004. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 304:452–54 [Google Scholar]
  90. Ochner CN, Laferrere B, Afifi L, Atalayer D, Geliebter A, Teixeira J. 90.  2012. Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci. Res. 74:138–43 [Google Scholar]
  91. Ochner CN, Stice E, Hutchins E, Afifi L, Geliebter A. 91.  et al. 2012. Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience 209:128–35 [Google Scholar]
  92. Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L. 92.  et al. 2006. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann. Surg. 244:715–22 [Google Scholar]
  93. Palmiter RD. 93.  2007. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci 30:375–81 [Google Scholar]
  94. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K. 94.  et al. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry 3:256–60 [Google Scholar]
  95. Randolph TG. 95.  1956. The descriptive features of food addiction; addictive eating and drinking. Q. J. Stud. Alcohol. 17:198–224 [Google Scholar]
  96. Ratsma JE, van der Stelt O, Schoffelmeer ANM, Westerveld A, Boudewijn Gunning W. 96.  2001. P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol. Clin. Exp. Res. 25:960–67 [Google Scholar]
  97. Ravussin E, Kozak LP. 97.  2004. Energy homeostasis. Pharmacotherapy of Obesity: Options and Alternatives KG Hofbauer, U Keller, O Boss 3–23 Boca Raton, FL: CRC Press [Google Scholar]
  98. Robinson TE, Berridge KC. 98.  2008. The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. B 363:3137–46 [Google Scholar]
  99. Saelens BE, Epstein LH. 99.  1996. Reinforcing value of food in obese and non-obese women. Appetite 27:41–50 [Google Scholar]
  100. Salamone JD, Correa M. 100.  2002. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 137:3–25 [Google Scholar]
  101. Salamone JD, Correa M. 101.  2013. Dopamine and food addiction: lexicon badly needed. Biol. Psychiatry 73:e15–24 [Google Scholar]
  102. Salgado S, Kaplitt MG. 102.  2015. The nucleus accumbens: a comprehensive review. Stereotact. Funct. Neurosurg. 93:75–93 [Google Scholar]
  103. Scheid JL, Carr KA, Lin H, Fletcher KD, Sucheston L. 103.  et al. 2014. FTO polymorphisms moderate the association of food reinforcement with energy intake. Physiol. Behav. 132:51–56 [Google Scholar]
  104. Schmidt JB, Pedersen SD, Gregersen NT, Vestergaard L, Nielsen MS. 104.  et al. 2016. Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial. Int. J. Obes. 40:281–90 [Google Scholar]
  105. Scholtz S, Goldstone AP, le Roux CW. 105.  2015. Changes in reward after gastric bypass: the advantages and disadvantages. Curr. Atheroscler. Rep. 17:61 [Google Scholar]
  106. Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML. 106.  et al. 2014. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63:891–902 [Google Scholar]
  107. Schultz W, Apicella P, Ljungberg T. 107.  1993. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13:900–13 [Google Scholar]
  108. Seeley RJ, Berridge KC. 108.  2015. The hunger games. Cell 160:805–6 [Google Scholar]
  109. Skibicka KP. 109.  2013. The central GLP-1: implications for food and drug reward. Front. Neurosci. 7:181 [Google Scholar]
  110. Small DM, Jones-Gotman M, Dagher A. 110.  2003. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage 19:1709–15 [Google Scholar]
  111. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. 111.  2001. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 124:1720–33 [Google Scholar]
  112. Smith DG, Robbins TW. 112.  2013. The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction model. Biol. Psychiatry 73:804–10 [Google Scholar]
  113. Smith JA, Epstein LH. 113.  1991. Behavioral economic analysis of food choice in obese children. Appetite 17:91–95 [Google Scholar]
  114. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G. 114.  et al. 2010. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42:937–48 [Google Scholar]
  115. Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO. 115.  et al. 2010. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes. Surg. 20:369–74 [Google Scholar]
  116. Steffen KJ, Engel SG, Wonderlich JA, Pollert GA, Sondag C. 116.  2015. Alcohol and other addictive disorders following bariatric surgery: prevalence, risk factors and possible etiologies. Eur. Eat. Disord. Rev. 23:442–50 [Google Scholar]
  117. Stice E, Burger KS, Yokum S. 117.  2013. Relative ability of fat and sugar tastes to activate reward, gustatory, and somatosensory regions. Am. J. Clin. Nutr. 98:1377–84 [Google Scholar]
  118. Stice E, Burger KS, Yokum S. 118.  2015. Reward region responsivity predicts future weight gain and moderating effects of the TaqIA allele. J. Neurosci. 35:10316–24 [Google Scholar]
  119. Stice E, Figlewicz DP, Gosnell BA, Levine AS, Pratt WE. 119.  2013. The contribution of brain reward circuits to the obesity epidemic. Neurosci. Biobehav. Rev. 37:2047–58 [Google Scholar]
  120. Stice E, Spoor S, Bohon C, Small DM. 120.  2008. Relation between obesity and blunted striatal response to food is moderated by TaqIA1 gene. Science 322:449–52 [Google Scholar]
  121. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. 121.  2008. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J. Abnorm. Psychol. 117:924–35 [Google Scholar]
  122. Stice E, Yokum S. 122.  2016. Neural vulnerability factors that increase risk for future weight gain. Psychol. Bull. 142:447–71 [Google Scholar]
  123. Stunkard AJ, Foch TT, Hrubec Z. 123.  1986. A twin study of human obesity. JAMA 256:51–54 [Google Scholar]
  124. Sun X, Kroemer NB, Veldhuizen MG, Babbs AE, de Araujo IE. 124.  et al. 2015. Basolateral amygdala response to food cues in the absence of hunger is associated with weight gain susceptibility. J. Neurosci. 35:7964–76 [Google Scholar]
  125. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S. 125.  et al. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479–84 [Google Scholar]
  126. 126. US Food Drug Admin. 2015. FDA expands uses of Vyvanse to treat binge-eating disorder FDA News Release, Jan. 30. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm432543.htm
  127. van der Hoek GA, Cooper SJ. 127.  1994. The selective dopamine uptake inhibitor GBR 12909: its effects on the microstructure of feeding in rats. Pharmacol. Biochem. Behav. 48:135–40 [Google Scholar]
  128. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK. 128.  et al. 2008. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage 42:1537–43 [Google Scholar]
  129. Volkow ND, Wang GJ, Tomasi D, Baler RD. 129.  2013. The addictive dimensionality of obesity. Biol. Psychiatry 73:811–18 [Google Scholar]
  130. Wang GJ, Volkow ND, Fowler JS. 130.  2002. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin. Ther. Targets 6:601–9 [Google Scholar]
  131. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT. 131.  et al. 2001. Brain dopamine and obesity. Lancet 357:354–57 [Google Scholar]
  132. Wang GJ, Volkow ND, Thanos PK, Fowler JS. 132.  2004. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J. Addict. Dis. 23:39–53 [Google Scholar]
  133. Wardle J, Carnell S, Haworth CM, Plomin R. 133.  2008. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am. J. Clin. Nutr. 87:398–404 [Google Scholar]
  134. White MJ, Morris CP, Lawford BR, Young RM. 134.  2008. Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav. Brain Funct. 4:54 [Google Scholar]
  135. Winkler JK, Woehning A, Schultz JH, Brune M, Beaton N. 135.  et al. 2012. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition 28:996–1001 [Google Scholar]
  136. Wise RA. 136.  1982. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav. Brain Sci. 5:39–87 [Google Scholar]
  137. Wise RA. 137.  2008. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox. Res. 14:169–83 [Google Scholar]
  138. Yeomans MR, Gray RW. 138.  2002. Opioid peptides and the control of human ingestive behaviour. Neurosci. Biobehav. Rev. 26:713–28 [Google Scholar]
  139. Yokum S, Gearhardt AN, Harris JL, Brownell KD, Stice E. 139.  2014. Individual differences in striatum activity to food commercials predict weight gain in adolescents. Obesity 22:2544–51 [Google Scholar]
  140. Yokum S, Marti CN, Smolen A, Stice E. 140.  2015. Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI. Appetite 87:38–45 [Google Scholar]
  141. Ziauddeen H, Farooqi IS, Fletcher PC. 141.  2012. Obesity and the brain: How convincing is the addiction model?. Nat. Rev. Neurosci. 13:279–86 [Google Scholar]
  142. Ziauddeen H, Fletcher PC. 142.  2013. Is food addiction a valid and useful concept?. Obes. Rev. 14:19–28 [Google Scholar]
/content/journals/10.1146/annurev-nutr-071816-064855
Loading
Brain on Fire: Incentive Salience, Hedonic Hot Spots, Dopamine, Obesity, and Other Hunger Games
Annual Review of Nutrition 37, 183 (2017); https://doi.org/10.1146/annurev-nutr-071816-064855
/content/journals/10.1146/annurev-nutr-071816-064855
/content/journals/10.1146/annurev-nutr-071816-064855
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error